 |
Most type 2 diabetes patients ‘unaware of heart risks’Seventy-four per cent of patients in the UAE don’t believe that type 2 diabetes is associated with increased cardiovascular risk, said the Emirates Diabetes Society in its findings of a Type 2 Diabetes Patient survey. The su More… |
 |
Type 2 diabetes victims misjudge heart disease riskOne in three people living with type 2 diabetes consider their risk of cardiovascular disease (CVD) to be low, said the International Diabetes Federation (IDF) in the interim results of the online survey on type 2 diabetes and CVD risk awareness More… |
 |
Kidney treatment for diabetes unveiled in UAEA new treatment that centres on the kidney in managing Type 2 diabetes, and which has been approved in Europe and the US, has now been introduced in the UAE, said experts at a recent medical forum in Dubai, UAE. Speaking at the sy More… |
 |
Ramadan app launched to support diabeticsMerck & Co (MSD), a leading pharmaceutical company, has launched a Ramadan app to aid Muslims with type 2 diabetes who choose to fast during Ramadan. The app will offer patients immediate access to the information kit “F More… |
 |
Coffee not linked to chronic illness: studyCoffee drinkers have no more risk of getting illnesses such as heart disease or cancer, and are less likely to develop type 2 diabetes, according to a German study involving more than 40,000 people over nearly a decade. More… |
 |
Onglyza reduces blood sugar levels: studyPharmaceutical companies Bristol-Myers Squibb and AstraZeneca have announced results from an investigational phase 3b clinical study of use of Onglyza (saxagliptin) in diabetic patients. The study was based on the addition of Onglyza (saxa More… |
 |
Linagliptin 'significantly lowers blood glucose'Phase III studies of Linagliptin, a compound being investigated by Boehringer Ingelheim as a once-daily oral treatment in type 2 diabetes, showed that the drug significantly lowered blood glucose, a report said. The drug, a dipeptidyl pept More… |
